Current Issues in Molecular Biology (Nov 2023)

miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy

  • Iga Dziechciowska,
  • Małgorzata Dąbrowska,
  • Anna Mizielska,
  • Natalia Pyra,
  • Natalia Lisiak,
  • Przemysław Kopczyński,
  • Magdalena Jankowska-Wajda,
  • Błażej Rubiś

DOI
https://doi.org/10.3390/cimb45120595
Journal volume & issue
Vol. 45, no. 12
pp. 9500 – 9525

Abstract

Read online

Breast cancer is one of the most commonly diagnosed cancer types worldwide. Regarding molecular characteristics and classification, it is a heterogeneous disease, which makes it more challenging to diagnose. As is commonly known, early detection plays a pivotal role in decreasing mortality and providing a better prognosis for all patients. Different treatment strategies can be adjusted based on tumor progression and molecular characteristics, including personalized therapies. However, dealing with resistance to drugs and recurrence is a challenge. The therapeutic options are limited and can still lead to poor clinical outcomes. This review aims to shed light on the current perspective on the role of miRNAs in breast cancer diagnostics, characteristics, and prognosis. We discuss the potential role of selected non-coding RNAs most commonly associated with breast cancer. These include miR-21, miR-106a, miR-155, miR-141, let-7c, miR-335, miR-126, miR-199a, miR-101, and miR-9, which are perceived as potential biomarkers in breast cancer prognosis, diagnostics, and treatment response monitoring. As miRNAs differ in expression levels in different types of cancer, they may provide novel cancer therapy strategies. However, some limitations regarding dynamic alterations, tissue-specific profiles, and detection methods must also be raised.

Keywords